# Prognostic Value of Oxygen-15 Water PET in Coronary Artery Disease

Study · id `cardio:ct-nct07932314` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07932314](<https://clinicaltrials.gov/study/NCT07932314>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07932314

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 40000 participants.

## Technical summary

Registry record NCT07932314. Allocation not applicable; no masking; primary purpose diagnostic. Start 2026-12 (anticipated); primary completion 2036-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Phase 3
- Enrolled: 40000 participants (planned count; ClinicalTrials.gov record NCT07932314, source copy `cardio:ctgov-nct07932314-2026-11-17`, retrieved 2026-11-18)
- Planned start: 2026-12 (anticipated) (ClinicalTrials.gov record NCT07932314, source copy `cardio:ctgov-nct07932314-2026-11-17`, retrieved 2026-11-18)
- Primary completion: 2036-12 (anticipated) (ClinicalTrials.gov record NCT07932314, source copy `cardio:ctgov-nct07932314-2026-11-17`, retrieved 2026-11-18)
- Completion: 2036-12 (anticipated) (ClinicalTrials.gov record NCT07932314, source copy `cardio:ctgov-nct07932314-2026-11-17`, retrieved 2026-11-18)
- Countries: Sweden (ClinicalTrials.gov record NCT07932314, source copy `cardio:ctgov-nct07932314-2026-11-17`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07932314-2026-11-17`, retrieved 2026-11-18)

## The registry's words

- Brief title: Prognostic Value of Oxygen-15 Water PET in Coronary Artery Disease
- Acronym: AQUA COR
- Condition: Coronary Artery Disease
- Condition: Microvascular Coronary Artery Disease
- Condition: Microvascular Coronary Dysfunction
- Intervention (Drug): Oxygen-15 Water
- Lead sponsor: Vastra Gotaland Region
- Lead sponsor class: OTHER\_GOV
- Collaborator: Sahlgrenska University Hospital
- Collaborator class: OTHER
- Collaborator: Gothia Forum - Center for Clinical Trial
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Vastra Gotaland Region (`cardio:org-vastra-gotaland-region`)
- Registry lists this organization as a collaborator: Sahlgrenska University Hospital (`cardio:org-sahlgrenska-university-hospital`)

## Provenance

Content hash: 94f7164940f083de6e59f116ab633ee29fbaf1824d60b3b0de5156e886781f65
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
